Article Information
History
- February 2, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- James T. Grist, BSc PhD1,2,3,4,
- Guilhem J. Collier, PhD5,
- Huw Walters, MBBS1,
- Mitchell Chen, BMBCh MEng DPhil FRCR1,
- Gabriele Abu Eid, BSc1,
- Aviana Laws1,
- Violet Matthews, BSc1,
- Kenneth Jacob, BSc1,
- Susan Cross, BSc1,
- Alexandra Eves, BSc1,
- Marianne Durant, BSc1,
- Anthony Mcintyre, BAppSci1,
- Roger Thompson, PhD6,
- Rolf F. Schulte, PhD7,
- Betty Raman, MBBS DPhil3,
- Peter A. Robbins, PhD2,
- Jim M. Wild, PhD MSc MA5,
- Emily Fraser, PhD MBChB BSc8 and
- Fergus Gleeson, MBBS1,9,*
- 1Department of Radiology, Oxford University Hospitals NHS Trust, Oxford, UK
- 2Department of Physiology, Anatomy, and Genetics, University of Oxford, UK
- 3Radcliffe Department of Medicine, Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford, UK
- 4Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK
- 5POLARIS, Department of Infection Immunity and Cardiovascular Disease, University of Sheffield
- 6Department of Infection, Immunity, and Cardiovascular Disease, University of Sheffield
- 7GE Healthcare, Munich, Germany
- 8Oxford Interstitial Lung Disease Service, Oxford University Hospitals NHS Trust, Oxford, UK
- 9Department of Oncology, University of Oxford, Oxford
- ↵*Corresponding Author:
Professor Fergus Gleeson, Department of Oncology, University of Oxford. email: fergus.gleeson{at}oncology.ox.ac.uk
Posted February 02, 2022.
The Investigation of Pulmonary Abnormalities using Hyperpolarised Xenon Magnetic Resonance Imaging in Patients with Long-COVID
